Vista previa | Fecha de publicación | Título | Autor(es) | Acceso |
![Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation-Genotypes Changes in Patients with Chronic Pain.pdf.jpg](/retrieve/ea9a64a5-72c7-4efd-b163-0458923f5c5e/Sex%20Differences%20in%20Opioid%20Response%20Linked%20to%20OPRM1%20and%20COMT%20genes%20DNA%20Methylation-Genotypes%20Changes%20in%20Patients%20with%20Chronic%20Pain.pdf.jpg) | 13-may-2023 | Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation/Genotypes Changes in Patients with Chronic Pain | Agulló, Laura; Muriel, Javier; Margarit, César; Escorial, Mónica; Garcia, Diana; Herrero, María José; Hervás, David; Sandoval, Juan; Peiró, Ana | ![](/image/openAccess.png) |
![Clinical prediction of opioid use disorder in chronic pain patients. A cohort-retrospective study with a pharmacogenetic approach.pdf.jpg](/retrieve/a558ddfe-37b5-4dd4-8872-0167dd3ecf23/Clinical%20prediction%20of%20opioid%20use%20disorder%20in%20chronic%20pain%20patients.%20A%20cohort-retrospective%20study%20with%20a%20pharmacogenetic%20approach.pdf.jpg) | 12-abr-2024 | Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach | Escorial, Mónica; Muriel, Javier; Agulló, Laura; Zandonai, Thomas; Margarit, César; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![Oxycodonenaloxone - naloxone versus tapentadol in real-world chronic non-cancer pain management.an observational and pharmacogenetic study.pdf.jpg](/retrieve/49e3f51c-59c2-43d1-9d15-6d348e3d5cf2/Oxycodonenaloxone%20-%20naloxone%20versus%20tapentadol%20in%20real-world%20chronic%20non-cancer%20pain%20management.an%20observational%20and%20pharmacogenetic%20study.pdf.jpg) | jun-2022 | Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study | Barrachina, Jordi; Margarit, César; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![Health benefits of an adverse events reporting system for.pdf.jpg](/retrieve/93c0dee0-48a8-43ca-8643-a94b8842a623/Health%20benefits%20of%20an%20adverse%20events%20reporting%20system%20for.pdf.jpg) | feb-2019 | Health benefits of an adverse events reporting system for chronic pain patients using long-term opioids | Planelles, Beatriz; Margarit, César; Ajo Ferrer, Raquel; Sastre, Yolanda; Muriel, Javier; Inda, María del Mar; Esteban, María D.; Peiró, Ana | ![](/image/openAccess.png) |
![OPRM1 Gene Interaction with Sleep in Chronic.pdf.jpg](/retrieve/ff761b6c-a378-41e7-9ff2-d98063c6767f/OPRM1%20Gene%20Interaction%20with%20Sleep%20in%20Chronic.pdf.jpg) | ene-2019 | OPRM1 Gene Interaction with Sleep in Chronic Pain Patients Treated with Opioids | Margarit, César; Ballester, Purificación; Inda, María del Mar; Roca, Reyes; Gomez, Luis; Planelles, Beatriz; Ajo Ferrer, Raquel; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![Randomized, Controlled, Crossover Study of.pdf.jpg](/retrieve/46dd496f-573d-43ea-b754-2568e08dd6ca/Randomized%2c%20Controlled%2c%20Crossover%20Study%20of.pdf.jpg) | nov-2018 | Randomized, Controlled, Crossover Study of Self-administered Jacobson Relaxation in Chronic, Nonspecific, Low-back Pain | Mateu, Margarita; ALDA, OLGA; Inda, María del Mar; Margarit, César; Ajo Ferrer, Raquel; Morales, Domingo; Van-der Hofstadt, Carlos; Peiró, Ana | ![](/image/openAccess.png) |
![OPRM1 influence on and effectiveness of an individualized.pdf.jpg](/retrieve/2da87291-5d23-4d1f-88b1-3db1c6061462/OPRM1%20influence%20on%20and%20effectiveness%20of%20an%20individualized.pdf.jpg) | ago-2018 | OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients | Muriel, Javier; Margarit, César; Planelles, Beatriz; Serralta, María J.; Puga, Carmen; Inda, María del Mar; Cutillas, Esperanza; Morales, Domingo; Horga, José Francisco; Peiró, Ana | ![](/image/openAccess.png) |
![Long-term deprescription in chronic pain and opioid use disorder patients. Pharmacogenetic and sex differences.pdf.jpg](/retrieve/442d251d-8781-4a09-b495-e3bbda10e4df/Long-term%20deprescription%20in%20chronic%20pain%20and%20opioid%20use%20disorder%20patients.%20Pharmacogenetic%20and%20sex%20differences.pdf.jpg) | 18-nov-2022 | Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences | Muriel, Javier; Escorial, Mónica; Margarit, César; Barrachina, Jordi; Carvajal, Cristian; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![Use of CYP2D6 substrates and inhibitors during pain management with.pdf.jpg](/retrieve/39c55ccd-30ac-4e83-820d-84383f96018a/Use%20of%20CYP2D6%20substrates%20and%20inhibitors%20during%20pain%20management%20with.pdf.jpg) | 14-jun-2024 | Use of CYP2D6 substrates and inhibitors during pain management with analgesic opioids: Drug-drug interactions that lead to lack of analgesic effectiveness | Muriel, J; Escorial, Mónica; Carratalá, C; Margarit, César; Barrachina, Jordi; López, A; Kringen, Marianne K; Peiró, Ana | ![](/image/openAccess.png) |
![Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting. An observational study.pdf.jpg](/retrieve/ca542327-61b5-4184-a433-b8037a6f0828/Therapeutic%20alliance%20impact%20on%20analgesic%20outcomes%20in%20a%20real-world%20clinical%20setting.%20An%20observational%20study.pdf.jpg) | 20-mar-2022 | Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting: An observational study | Barrachina, Jordi; Margarit, César; Andreu, Blanca; Zandonai, Thomas; Ballester, Purificación; Muriel, Javier; Cutillas, Esperanza; Peiró, Ana | ![](/image/openAccess.png) |